[Expert Solution]: Mrs. Anderson, a 65-year-old female, has a his

Mrs. Anderson, a 65-year-old female, has a history of recurrent major depressive disorder that has not responded well to conventional antidepressant therapy. Due to the lack of improvement, her psychiatrist has prescribed a monoamine oxidase inhibitor (MAOI), specifically phenelzine (Nardil). Mrs. Anderson has been educated on dietary restrictions and potential drug interactions associated with MAOIs. Scenario: One month into the treatment with phenelzine, Mrs. Anderson experiences a sudden onset of confusion, agitation, diaphoresis, and tremors. She is brought to the emergency department by her family. The healthcare team suspects serotonin syndrome and must assess the situation promptly. What drug class do you think Mrs. Anderson took for her major depressive disorder prior to starting MAOI? How long should she have waited between therapies? What are the common signs and symptoms of serotonin syndrome? What are the more severe symptoms of serotonin syndrome? Please discuss the dietary restrictions associated with MAOIs that should be included in patient education for Mrs. Anderson.